Adam Scott Levy, CFO and Secretary at Mineralys Therapeutics, Inc. (MLYS), sold 21,514 shares at $13.57 ($292K) on 2024-10-11, disclosed to the SEC on 2024-10-15.
Scheduled sale ($292k) by CFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.57 | 10,757 | $146K | 50.0% |
| 2 | $13.57 | 10,757 | $146K | 50.0% |
| Total | $13.57 avg | 21,514 | $292K | 100% |
| Filing → |
| MLYS | SELL | 2025-10-15 | $904K | — | Filing → |
| MLYS | SELL | 2025-07-30 | $1.4M | — | Filing → |
| MLYS | SELL | 2025-07-15 | $311K | — | Filing → |